Harvard Bioscience (HBIO) Current Deferred Tax Assets (2010 - 2015)

Harvard Bioscience (HBIO) has 6 years of Current Deferred Tax Assets data on file, last reported at $42000.0 in Q4 2015.

• On a quarterly basis, Current Deferred Tax Assets fell 97.23% year-over-year to $42000.0 in Q4 2015; TTM through Dec 2015 was $42000.0, a 97.23% decrease from a year earlier, with the FY2015 full-year figure at $42000.0, down 97.23% from the prior year.
• Current Deferred Tax Assets for Q4 2015 stood at $42000.0, down from $2.6 million in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for HBIO reached as high as $5.7 million in Q3 2011 and fell as low as $42000.0 in Q4 2015.
• Historically, Current Deferred Tax Assets has averaged $2.5 million across 5 years, with a median of $1.6 million in 2013.
• On a YoY basis, Current Deferred Tax Assets climbed as much as 68.8% in 2015 and fell as far as 97.23% in 2015.
• Year by year, Current Deferred Tax Assets stood at $3.9 million in 2011, then sank by 60.26% to $1.6 million in 2012, then retreated by 0.39% to $1.5 million in 2013, then decreased by 2.07% to $1.5 million in 2014, then sank by 97.23% to $42000.0 in 2015.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $42000.0 in Q4 2015, $2.6 million in Q3 2015, and $2.6 million in Q2 2015.